Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 19Carcinoma, Hepatocellular 15Brain Neoplasms 12Breast Neoplasms 10Pancreatic Neoplasms 9Neoplasm Metastasis 9Lung Neoplasms 5Neoplasms 4Recurrence 3Colorectal Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroma, Acoustic 2NSCLC 2Liver Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Esophageal Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1Stage IA - IB Non Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Spine Metastasis 1Spinal Neoplasms 1Spinal Bone Metastases 1Solid Tumor 1Sarcoma 1Rare Diseases 1Radiotherapy 1

Interventions

Gefitinib 5icotinib 4Pemetrexed 4Docetaxel 4camrelizumab 3apatinib 3anlotinib 3aflutinib 3Erlotinib Hydrochloride 3osimertinib 2dacomitinib 2Thalidomide 2Radiosurgery 2Drug Therapy 2Carboplatin 2Afatinib 2trilaciclib 1spartalizumab 1pembrolizumab 1nimotuzumab 1famitinib 1envafolimab 1Vinorelbine 1Tyrosine Kinase Inhibitors 1S 1 (combination) 1Radiofrequency Ablation 1Microphysiological Systems 1Immune Checkpoint Inhibitors 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × NSCLC × Radiosurgery × Clear all
NCT03256981 2023-12-26

HALT

Institute of Cancer Research, United Kingdom

Phase 2/3 Unknown
113 enrolled
Thoracic

NSCLC

NCT02975609 2016-11-29

Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

Shanghai Chest Hospital

Phase 2 Unknown
100 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡